Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...

Pfizer announces a licensing agreement with 3SBio to develop, manufacture and commercialize SSGJ-707 globally, excluding China. Ready to turn the market’s comeback into steady cash flow?

Rep. Russell Fry, R-S.C., discusses the House probe into Pfizer’s release of COVID vaccine results and more on ‘Varney & Co.’ Letitia James reacts after judge rebukes Trump admin 8 Things ...

North Carolina has pulled its economic incentive for the drug manufacturing giant Pfizer to hire hundreds of workers in the Lee County seat of Sanford. The decision Wednesday arrived three months ...

The HER2-targeted antibody-drug conjugate that Pfizer gained from its Seagen buyout has delivered positive results in a pivotal study among Chinese patients with newly diagnosed bladder cancer ...

Pharmaceutical giant Pfizer Inc. PFE has signed a significant licensing agreement with China's 3SBio Inc. for an experimental cancer drug, SSGJ-707. According to the deal, Pfizer will pay $1.25 ...

May 19 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab said it would license an experimental cancer treatment from China's 3SBio Inc (1530.HK), opens new tab, paying $1.25 billion upfront ...

SO YES, WE STILL NEED TO BE TAKING IT SERIOUSLY. The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an ...

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China. Pfizer has entered into an exclusive global licensing agreement with 3SBio to ...

GROTON, CT (WFSB) - A fire broke out early Tuesday morning at the Flagship Inn and Suites in Groton. The fire forced 20 guests out of their rooms and damaged 16 units, according to fire officials ...

Citing new information from British drugmaker GSK, U.S. lawmakers are pushing forward with a probe into a pandemic-era political controversy centered around the timing of trial results for Pfizer ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks on Jim Cramer’s radar recently. On Monday’s episode of Mad Money, Jim Cramer broke down ...